Weave Communications Inc. Common Stock (WEAV)
FairStock Score: 51/100 — MIXED
Key Financials
| Current Price | $7.4 |
| Market Cap | $592M |
| P/E Ratio | -27.41 |
| ROE | -25.08% |
| Dividend Yield | —% |
| Sector | Healthcare |
AI Analysis
AI-generated, general educational analysis — not personal investment advice.
I look for a durable business bought at a sensible price. Weave sells communications and payment software to small medical practices, a useful niche, but the numbers do not yet show a wide moat or proven earning power. Revenue grew from $170.5 million in fiscal 2023, the year ended 2023-12-31, to $204.3 million in fiscal 2024, the year ended 2024-12-31, and to $239.0 million in fiscal 2025, the year ended 2025-12-31. Quarterly revenue rose from $58.5 million in fiscal Q2 2025, the quarter ended 2025-06-30, to $67.5 million in fiscal Q2 2026, the quarter ended 2026-06-30. Net loss narrowed from $8.7 million in fiscal Q2 2025, the quarter ended 2025-06-30, to $4.3 million in fiscal Q2 2026, the quarter ended 2026-06-30. That is progress, but the company still lost $28.1 million in fiscal 2025, the year ended 2025-12-31, and has lost money in each of the last four years, so the Peter Lynch category is none. Financial health is mixed. Trailing free cash flow was $11.0 million, only a FairStock FCF yield of 1.9% on the $589.6 million market cap. The FairStock Piotroski score is 6/9, and the Altman Z-score is 1.03, which warns of balance-sheet risk. Debt-to-equity is 0.60. The FairStock P/B is 7.02 and P/E is -27.30 based on the close of $7.37 on 2026-10-13; FairStock ROE is -25.08% and ROCE is -6.23%. The 52-week range is $4.24 to $7.70, so the price sits near the top of that range. I would need consistent positive net income and stronger free cash flow before calling this a value opportunity.
In plain English: Weave sells software that helps small and medium healthcare practices communicate with patients and take payments. Revenue is growing and losses are getting smaller, but the company still has not made a yearly profit and its cash generation is modest. At the recent price of $7.37, the shares look expensive compared with current profits and not cheap compared with cash flow.
The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.
Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash
Sources (SEC EDGAR): fiscal Q2 2026 10-Q (period ended 2026-06-30) · fiscal Q1 2026 10-Q (period ended 2026-03-31) · fiscal Q3 2025 10-Q (period ended 2025-09-30) · fiscal Q2 2025 10-Q (period ended 2025-06-30) · FY2025 10-K (period ended 2025-12-31) · FY2024 10-K (period ended 2024-12-31) · FY2023 10-K (period ended 2023-12-31)
Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer